Controlling Nutritional Status Score and Early Posttransplant Outcomes: Infection Risk and Acute Rejection in Kidney Transplant Recipients
Transplantation Proceedings · 2026
DOI: 10.1016/j.transproceed.2026.07.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Muhammed Emre Sevim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Nephrology, Dicle University, Diyarbakır, Türkiye. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, Nutritional Status, Infections. Die Arbeit nennt 38 Literaturangaben.
Themen: Mangelernährung
Abstract (Originalsprache)
BACKGROUND: Nutritional and immune status influence kidney transplant outcomes, yet the prognostic value of the Controlling Nutritional Status (CONUT) score remains unclear. MATERIALS AND METHODS: We retrospectively analyzed 129 adult kidney transplant recipients at a single center. Patients were stratified by pretransplant CONUT score into low (≤4) and high (≥5) groups. The primary endpoint was infection requiring hospitalization and intravenous (IV) antibiotics within 6 months posttransplant. Biopsy-proven acute rejection (BPAR) developing within the first 6 months was evaluated as a secondary outcome. RESULTS: There were 48 (37.2%) patients in the CONUT ≥5 group and 81 (62.8%) patients in the CONUT ≤4 group. Infections developed in 56 patients during the post-transplant period. Infections occurred significantly more frequently in the high CONUT group (60.4% vs. 33.3%, p = .017), with longer infection-related hospitalization (median 18 vs. 10 days, p = .008). On multivariate logistic regression analysis, CONUT ≥5 group independently predicted infection (OR=2.64, 95% CI 1.06-6.59, p = .037). ROC analysis identified a cutoff of 4.5 (AUC 0.629, p = .037). BPAR developed in 29 patients. The incidence of BPAR was higher in the CONUT ≥5 group (35.4% vs. 14.8%, p = .016), while no significant differences were observed for chronic rejection or graft loss. Mean graft survival was 110.0 ± 10.1 months in CONUT ≥5 and 121.4 ± 7.2 months in CONUT ≤4 patients (p = .47). CONCLUSIONS: Preoperative CONUT score may be an independent predictor of early serious infection after kidney transplantation. It may also be related to BPAR, which develops within 6 months. The CONUT score may serve as a simple and practical tool for infection and BPAR risk stratification in routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Medicine, Department of Nephrology, Dicle University, Diyarbakır, Türkiye.
- Faculty of Medicine, Department of Nephrology, Dicle University, Diyarbakır, Türkiye. Electronic address: emreaydin83@hotmail.com.
- Department of Internal Medicine, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Türkiye.
- Department of Nephrology, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Türkiye.
- Faculty of Medicine, Department of Internal Medicine, Dicle University, Diyarbakır, Türkiye.
Zitieren
APA
Sevim, M. E., Aydın, E., Zümrüt Sevim, P., İnce, H., Akçay, Ş., Yılmaz, Z., Yıldırım, Y., & Yılmaz Aydın, F. (2026). Controlling Nutritional Status Score and Early Posttransplant Outcomes: Infection Risk and Acute Rejection in Kidney Transplant Recipients. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.07.018
Vancouver
Sevim ME, Aydın E, Zümrüt Sevim P, İnce H, Akçay Ş, Yılmaz Z, et al. Controlling Nutritional Status Score and Early Posttransplant Outcomes: Infection Risk and Acute Rejection in Kidney Transplant Recipients. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.07.018
BibTeX
@article{Sevim2026,
author = {Sevim, Muhammed Emre and Aydın, Emre and Zümrüt Sevim, Pelda and İnce, Hasan and Akçay, Şeyhmus and Yılmaz, Zülfükar and Yıldırım, Yaşar and Yılmaz Aydın, Fatma},
title = {Controlling Nutritional Status Score and Early Posttransplant Outcomes: Infection Risk and Acute Rejection in Kidney Transplant Recipients},
journal = {Transplantation Proceedings},
year = {2026},
doi = {10.1016/j.transproceed.2026.07.018}
}
EUVIMED